[Hong Kong] Fight Covid-19: How innovative Hong Kong biotech companies aim to help people battle coronavirus disease
Auteurs : Scott Murphy, journaliste de South China Morning Post à Hong Kong
Production : South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.
Diffusion : site du journal South China Morning Post
Date et Heure : 21 avril 2020, 11:30
– With coronavirus on everyone’s minds, two biotech companies based at Hong Kong Science Park show they are ahead of the curve
– Sanwa BioTech’s medical diagnostic platform and Govita Tech, a biotech health assessment firm, both working on concepts to tackle the outbreak
Source : Scott Murphy, “Fight Covid-19: How innovative Hong Kong biotech companies aim to help people battle coronavirus disease”, South China Morning Post, 21/04/2020. URL : https://www.scmp.com/presented/tech/innovation/topics/healthy-living-tech-good/article/3080809/fight-covid-19-how (consulté le 15/05/2020).
Photo “à la une” : Kelvin Chiu, CEO of Sanwa BioTech, has developed a rapid, portable and accurate diagnostic solution to help medical professionals monitor and control diseases. © Norm Yip
OpenEdition vous propose de citer ce billet de la manière suivante :
Admin IAO (21 avril 2020). [Hong Kong] Fight Covid-19: How innovative Hong Kong biotech companies aim to help people battle coronavirus disease. Asie Orientale et Coronavirus. Consulté le 20 mars 2025 à l’adresse https://doi.org/10.58079/n72k